Clinical Trials in Dunkirk, France
19 recruiting
Showing 1–20 of 21 trials
Recruiting
Phase 3
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
Diffuse Large B Cell Lymphoma
Merck Sharp & Dohme LLC1,046 enrolled253 locationsNCT06717347
Recruiting
Phase 3
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Multiple Myeloma
Pfizer492 enrolled121 locationsNCT06152575
Recruiting
Origin and Function of Eosinophilic Polynuclear During DRESS Syndrome
Drug hypersensitivityDRESS Syndrome
University Hospital, Lille80 enrolled11 locationsNCT04330118
Recruiting
Phase 3
Effect of CAFfeine on Cognition in Alzheimer's Disease
Alzheimer Disease
University Hospital, Lille248 enrolled17 locationsNCT04570085
Recruiting
Phase 2
Study of Lacutamab in Peripheral T-cell Lymphoma
Relapse/RecurrencePeripheral T Cell Lymphoma
The Lymphoma Academic Research Organisation56 enrolled64 locationsNCT04984837
Recruiting
French Prospective Observational Study in Patients Eligible for Systemic Therapy for Atopic Dermatitis (AD)
Atopic Dermatitis
Sanofi600 enrolled60 locationsNCT06837454
Recruiting
Phase 3
Elranatamab/Lenalidomide Consolidation and/or Elranatamab Maintenance Versus Standard of Care After D-VRd Induction in Transplant-eligible NDMM Patients
Multiple Myeloma, Newly Diagnosed
Intergroupe Francophone du Myelome824 enrolled64 locationsNCT06918002
Recruiting
Observational Study to Evaluate Long-Term Outcome in Hip Arthroplasty
Hip ReplacementFemur Head NecrosisPrimary, Secondary or Post-traumatic Osteoarthrosis+2 more
Corin2,500 enrolled13 locationsNCT02230826
Recruiting
Phase 4
Comparison of a Personalized Maintenance Therapy With the Standard Treatment in Pemphigus
PemphigusDermatologic Disease
University Hospital, Rouen133 enrolled34 locationsNCT05898308
Recruiting
Glofitamab in Real Life
Large B-cell Lymphoma
The Lymphoma Academic Research Organisation250 enrolled30 locationsNCT06994169
Recruiting
Not Applicable
6-month Efficacy and Safety of Synolis VA 80/160 in Hip Osteoarthritis
Osteoarthritis, Hip
Aptissen SA70 enrolled3 locationsNCT05829733
Recruiting
OBServatory of Compassionate Use of IVOsidenib in France for Patients With Acute Myeloid Leukemia
AML, Adult
French Innovative Leukemia Organisation250 enrolled21 locationsNCT06377579
Recruiting
Phase 2
Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients Without Progression and With no More Than Three Residual Metastatic Lesions Following First Line Systemic Therapy
Urothelial Bladder Cancer
Institut Claudius Regaud130 enrolled20 locationsNCT04428554
Recruiting
Prospective Non-interventional Study of Adult Patients With Acute Myeloid Leukemia (AML)
Acute Myeloid Leukemia (AML)
Acute Leukemia French Association5,000 enrolled30 locationsNCT04777916
Recruiting
Phase 2
Study of Teclistamab in Combination in Elderly Patients With Multiple Myeloma
Multiple Myeloma
University Hospital, Lille74 enrolled29 locationsNCT05572229
Recruiting
Not Applicable
Telemonitoring Platform "CUREETY TECHCARE" vs Standard of Care for mTBNC Patients Initiating a First-line Treatment
Metastatic Triple-Negative Breast Carcinoma
UNICANCER472 enrolled51 locationsNCT06505018
Recruiting
Diagnostic Performance of Spot Urine Sample for the Monoclonal Components Detection in Patients With Multiple Myeloma
Multiple Myeloma
Intergroupe Francophone du Myelome180 enrolled20 locationsNCT05208086
Recruiting
Phase 2Phase 3
Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CR
Acute Myeloid Leukemia (AML)
University Hospital, Angers3,100 enrolled56 locationsNCT02416388
Recruiting
Not Applicable
Early Discontinuation of Empirical Antifungal Therapy and Biomarkers
Invasive Candidiasis
University Hospital, Lille194 enrolled10 locationsNCT03538912
Recruiting
Not Applicable
Transplantation After Complete Response In Patients With T-cell Lymphoma
Peripheral T Cell Lymphoma
Hospices Civils de Lyon204 enrolled48 locationsNCT05444712